ProKidney Corp (NASDAQ: PROK) flaunted slowness of -1.60% at $1.85, before settling in for the price of $1.88 at the close. Taking a more long-term approach, PROK posted a 52-week range of $1.18-$4.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -2.23%. This publicly-traded company’s shares outstanding now amounts to $127.97 million, simultaneously with a float of $76.97 million. The organization now has a market capitalization sitting at $539.66 million. At the time of writing, stock’s 50-day Moving Average stood at $1.8418, while the 200-day Moving Average is $2.1817.
ProKidney Corp (PROK) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the ProKidney Corp industry. ProKidney Corp’s current insider ownership accounts for 39.85%, in contrast to 43.14% institutional ownership. According to the most recent insider trade that took place on Sep 19 ’24, this organization’s Chief Regulatory Officer sold 16,412 shares at the rate of 2.50, making the entire transaction reach 41,030 in total value, affecting insider ownership by 103,480.
ProKidney Corp (PROK) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
ProKidney Corp’s EPS decrease for this current 12-month fiscal period is -2.23% and is forecasted to reach -0.42 in the upcoming year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
Let’s observe the current performance indicators for ProKidney Corp (PROK). It’s Quick Ratio in the last reported quarter now stands at 17.09. The Stock has managed to achieve an average true range (ATR) of 0.18.
In the same vein, PROK’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.56, a figure that is expected to reach -0.15 in the next quarter, and analysts are predicting that it will be -0.42 at the market close of one year from today.
Technical Analysis of ProKidney Corp (PROK)
Now, what If we examine the latest scores posted by [ProKidney Corp, PROK]. During the last 5-days, its volume was lower the volume of 0.7 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 48.09% While, its Average True Range was 0.1853.
Raw Stochastic average of ProKidney Corp (PROK) in the period of the previous 100 days is set at 33.33%, which indicates a major fall in contrast to 45.75% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 129.30% that was higher than 99.06% volatility it exhibited in the past 100-days period.
